FDA 483 - Scott A. Fretzin, M.D. - May 01, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Scott A. Fretzin, M.D. in Indianapolis, IN, identified a failure to conduct a clinical study in accordance with good clinical practices. The inspection revealed issues with enrolling subjects who did not meet protocol-required eligibility criteria and a lack of adherence to the investigational plan, including maintaining primary source documents for washout periods. These findings indicate significant deficiencies in the oversight and execution of the clinical trial.
ID · e156250b-3071-40eb-9275-5de57a82023a